BLOG

Beyond Surgery: How NK Cell Therapy Can Help Manage Recurrence Risk

7 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

For many who undergo cancer surgery, the removal of a visible tumor marks a significant milestone. Yet, a common concern that follows is the risk of recurrence. This can happen when microscopic cancer cells, undetectable by current imaging technology, remain in the body. Addressing this challenge is a key focus of modern oncology. One approach is the use of adjuvant therapies—treatments given after the primary treatment—to help lower the risk of the cancer returning. This article explores how NK cell therapy can function as an adjuvant treatment, aiming to support the body’s own immune system in this important phase of care.

The Post-Surgery Challenge: Understanding Minimal Residual Disease

Even after a surgeon has successfully removed all visible signs of a tumor, a small number of cancer cells can sometimes be left behind. This is known as Minimal Residual Disease (MRD). These are tiny, invisible seeds of the cancer that are too small to be seen on scans but have the potential to multiply over time and lead to a recurrence. The goal of adjuvant therapy is to address these remaining cells. While chemotherapy and radiation are common adjuvant treatments, immunotherapy, which harnesses the body’s own immune system, offers another strategy. This is where the concept of strengthening immune surveillance after surgery becomes particularly relevant.

What Is Adjuvant NK Cell Therapy?

NK (Natural Killer) cell therapy is a type of cancer immune cell therapy. NK cells are a specialized component of our innate immune system—the body’s first line of defense. Their primary function is to patrol the body, rapidly identifying and destroying abnormal cells, such as cancer cells, without needing prior instructions or “training.” However, the activity of NK cells can decline due to factors like age, stress, or the cancer itself.

In NK cell therapy, a sample of your own blood is drawn. From this sample, your NK cells are isolated, then activated and expanded in number in a specialized cell processing facility. These enhanced cells are then returned to your body through an intravenous (IV) infusion. As an adjuvant treatment, the therapy aims to increase the number and activity of these vigilant immune cells, thereby reinforcing your body’s natural ability to find and eliminate any lingering cancer cells after surgery.

How NK Cells May Bolster Post-Surgical Immune Surveillance

The unique characteristics of NK cells make them well-suited for the task of immune surveillance against minimal residual disease. Unlike other immune cells that need to be activated by specific signals to recognize a target, NK cells can attack abnormal cells on sight. They are particularly effective at recognizing cells that try to hide from the immune system. Some cancer cells evade detection by reducing specific markers (MHC molecules) on their surface, but NK cells are adept at identifying and eliminating precisely these types of stealthy cells.

By reintroducing a larger, more active population of your own NK cells, the therapy seeks to enhance this natural defense mechanism. The goal is to create a more robust surveillance system that can effectively patrol the body and address microscopic disease before it has a chance to develop into a detectable recurrence. This approach is based on supporting the body’s inherent ability to protect itself.

Integrating NK Cell Therapy with Standard Cancer Care

It is essential to understand that NK cell therapy is not presented as a replacement for standard cancer treatments like surgery, chemotherapy, or radiation therapy. Instead, it can be used alongside them as a complementary, or adjuvant, approach. It may be a consideration for individuals who have completed their primary treatment and are focused on strategies to manage the risk of recurrence.

This treatment is a private medical service, meaning it is not covered by Japanese public health insurance. In Japan, cell therapies like this are provided under specific regulations, such as the Act on the Safety of Regenerative Medicine, which ensures that cell processing and treatment administration meet strict safety and quality control standards. As with any medical treatment, outcomes are not guaranteed and can vary between individuals. A comprehensive consultation with a physician is necessary to determine if this therapy is a suitable option for your specific medical condition and history.

Key Considerations Before Your Consultation

If you are considering adjuvant NK cell therapy, a thorough discussion with a medical professional is the most important first step. To help you prepare for your consultation, it is useful to think about the following points:

  • Your Medical History: Be prepared to discuss your specific cancer diagnosis, stage, and the treatments you have already received.
  • Treatment Plan Integration: Ask how NK cell therapy might fit into your overall, long-term care plan.
  • The Process: Inquire about the treatment process, including the number of sessions and the expected timeline.
  • Potential Risks and Side Effects: As this therapy uses your own cells, serious side effects like rejection are not anticipated. However, temporary symptoms such as fever or fatigue may occur. A physician must explain all potential risks and side effects based on your individual health condition before treatment.
  • Associated Costs: As a treatment not covered by public insurance, you should confirm the full costs involved.

At Grand Green Osaka Umekita Clinic, we believe in empowering patients with clear, accessible information. For more details on the features, process, and considerations of this treatment, please review our NK Cell Therapy information page.

Summary: A Supportive Step in Post-Surgery Care

Successfully removing a tumor with surgery is a major step in cancer treatment, but the journey often continues with a focus on managing the risk of recurrence. Adjuvant therapies play a supportive role in this next phase. NK cell therapy represents an approach that leverages your body’s own immune system to enhance surveillance against minimal residual disease. It is not a standalone cure but a complementary option that can be integrated with conventional care under the guidance of a physician.

If you are exploring cancer treatment options in Japan and are located in or near Osaka, we invite you to learn more. A medical professional at Grand Green Osaka Umekita Clinic can provide personalized advice based on your unique health situation and help you understand all available options.

Learn more about NK Cell Therapy

References

Supervising Physician

Hidenori Shimada

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Back to article list › Back to NK Cell Therapy ›

Grand Green Osaka South Building, Gate Tower 5F 5-54 Ofuka-cho, Kita-ku, Osaka 530-0011, Japan

TEL: 06-7653-8493 FAX: 06-7635-8052

Contact